title: Pneumococcal vaccine and opsonic pneumococcal antibody.
abstract: Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further improve the conjugate vaccines. However, in children new pneumococcal vaccines can no longer be tested with placebo-based clinical trials because effective vaccines are currently available. Thus, vaccine studies must depend on surrogate markers of vaccine efficacy. Although traditional antibody levels (e.g., ELISA) are useful as a surrogate marker of protection, they have limitations, and a bioassay measuring the capacity of antibodies to opsonize pneumococci has been developed. This opsonophagocytosis assay (OPA) replicates the in vivo mechanism of antibody protection and should therefore better reflect protection by vaccine-induced antibodies. Technical improvements of OPA have made this bioassay rapid, multiplexed, and practical for analyzing small samples including those from children. Strong correlations between ELISA and OPA have been observed in many studies of young children. However, poor correlations have been found in some important clinical situations (such as determination of protection by cross-reactive antibodies) and populations (such as elderly adults and immunodeficient patients). In these settings, OPA has become a useful supplementary measure of pneumococcal vaccine immunogenicity. Current efforts to standardize OPA will further expand its uses.
authors: Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors: Joon Young
authors: JY
authors: Song
authors: M Allen
authors: MA
authors: Moseley
authors: Robert L
authors: RL
authors: Burton
authors: Moon H
authors: MH
authors: Nahm
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D003584:Cytological Techniques; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009895:Opsonin Proteins / Q000097:blood / Q000276:immunology*; D010587:Phagocytosis; D022242:Pneumococcal Vaccines / Q000276:immunology* / Q000494:pharmacology*; D013296:Streptococcus pneumoniae / Q000276:immunology*; D018074:Vaccines, Conjugate / Q000276:immunology / Q000494:pharmacology
chemical_list: D000907:Antibodies, Bacterial; D015415:Biomarkers; D009895:Opsonin Proteins; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate
references: J Infect Dis. 1983 Dec;148(6):1136-59
references: 6361173
references: Lancet. 2009 Sep 12;374(9693):893-902
references: 19748398
references: Clin Vaccine Immunol. 2012 Jun;19(6):835-41
references: 22518015
references: Clin Vaccine Immunol. 2009 Mar;16(3):376-81
references: 19144787
references: Vaccine. 2007 May 16;25(20):4029-37
references: 17391816
references: J Immunol. 2012 Dec 1;189(11):5327-35
references: 23105137
references: J Clin Microbiol. 1995 Oct;33(10):2759-62
references: 8567920
references: Vaccine. 2010 Jun 7;28(25):4192-203
references: 20417262
references: Cell Physiol Biochem. 2010;25(1):13-26
references: 20054141
references: MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8
references: 18272956
references: Lancet. 2006 Oct 28;368(9546):1495-502
references: 17071283
references: Vaccine. 2007 May 10;25(19):3816-26
references: 17368878
references: Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9
references: 12853378
references: Pediatr Infect Dis J. 2011 Dec;30(12):e235-43
references: 21817957
references: Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S66-76
references: 19325449
references: J Immunol Methods. 1999 Dec 17;232(1-2):15-22
references: 10618506
references: Pediatrics. 2010 Sep;126(3):e493-505
references: 20732948
references: Bone Marrow Transplant. 2001 Jan;27(2):207-11
references: 11281392
references: Scand J Infect Dis. 1992;24(3):357-60
references: 1509241
references: Vaccine. 2001 Nov 12;20(3-4):545-53
references: 11672921
references: Vaccine. 2013 Jan 21;31(5):845-9
references: 23153440
references: Hum Vaccin Immunother. 2012 Feb;8(2):161-73
references: 22426374
references: Clin Diagn Lab Immunol. 1998 Sep;5(5):703-10
references: 9729539
references: Clin Infect Dis. 2012 Sep;55(5):e35-44
references: 22652582
references: Clin Vaccine Immunol. 2006 Sep;13(9):1004-9
references: 16960111
references: J Clin Microbiol. 2007 Apr;45(4):1225-33
references: 17267625
references: Lancet Infect Dis. 2007 Sep;7(9):597-606
references: 17714673
references: J Trauma. 1998 May;44(5):760-5; discussion 765-6
references: 9603075
references: Clin Diagn Lab Immunol. 1997 Jul;4(4):415-22
references: 9220157
references: J Infect Dis. 2003 May 15;187(10):1639-45
references: 12721944
references: Clin Infect Dis. 2012 Jul;55(2):265-7
references: 22495544
references: Clin Microbiol Rev. 2010 Oct;23(4):740-80
references: 20930072
references: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001390
references: 17054135
references: Vaccine. 2013 Jan 2;31(2):327-33
references: 23153437
references: Clin Diagn Lab Immunol. 2003 Jul;10(4):616-21
references: 12853394
references: Clin Infect Dis. 2009 Jul 15;49(2):241-8
references: 19522655
references: Infect Immun. 2011 Jan;79(1):314-20
references: 21041499
references: J Immunol. 2008 Nov 15;181(10):7138-46
references: 18981135
references: Clin Diagn Lab Immunol. 2003 Nov;10(6):1019-24
references: 14607861
references: J Immunol. 1986 Dec 1;137(11):3484-7
references: 3782789
references: Clin Vaccine Immunol. 2012 Aug;19(8):1296-303
references: 22739693
references: J Infect Dis. 2005 Aug 1;192(3):377-86
references: 15995950
references: Immunity. 2005 May;22(5):539-50
references: 15894272
references: Clin Diagn Lab Immunol. 2005 Jan;12(1):19-27
references: 15642980
references: Clin Infect Dis. 2008 Apr 1;46(7):1015-23
references: 18444818
references: Vaccine. 2004 Sep 28;22(29-30):4014-20
references: 15364451
references: Clin Vaccine Immunol. 2006 Mar;13(3):356-60
references: 16522777
references: Science. 1998 Nov 27;282(5394):1717-21
references: 9831565
references: J Exp Med. 1931 Jun 30;54(1):73-89
references: 19869903
references: Vaccine. 2003 Jul 4;21(23):3265-72
references: 12804857
references: Clin Infect Dis. 1999 Aug;29(2):281-8
references: 10476727
references: J Infect Dis. 2008 Oct 1;198(7):1019-27
references: 18710324
references: Vaccine. 2008 Oct 9;26(43):5521-6
references: 18706464
references: Vaccine. 2011 Apr 18;29(18):3398-412
references: 21397721
references: Clin Vaccine Immunol. 2012 Oct;19(10):1618-23
references: 22875604
references: Pediatr Infect Dis J. 1999 Sep;18(9):757-63
references: 10493334
references: JAMA. 1979 Jun 15;241(24):2619-21
references: 374767
references: Clin Vaccine Immunol. 2006 Feb;13(2):165-9
references: 16467321
references: Wkly Epidemiol Rec. 2007 Mar 23;82(12):93-104
references: 17380597
references: Clin Vaccine Immunol. 2006 Apr;13(4):459-66
references: 16603613
references: Vaccine. 2007 Aug 14;25(33):6164-6
references: 17629361